Our previous studies (unpublished data) evaluate and correlate the expression levels of p53, bcl-2, NF-kb, Cripto-1 and Ki67 proliferation index in prostate cancer (Pca) patients treated with radical radiotherapy and their association with clinicopathological profiles and disease outcomes. The gene discussed is TP53; the disease is prostate cancer.